Skip to main content
Clinical Trials/NL-OMON42377
NL-OMON42377
Completed
N/A

Optimizing cardiac resynchronization therapy with the use of an implantable heart monitor - Optimizing CRT with IHM

Academisch Medisch Centrum0 sites20 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Academisch Medisch Centrum
Enrollment
20
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • \*Class I or IIa criteria of the 'European Society of Cardiology' for cardiac resynchronisation.
  • \*Class III heart failure according to the 'New York Heart Association' with a hospitalization for hartfailure in the previous year.
  • \*Willing and able to understand and comply with the study requirements and providing a signed informed consent.

Exclusion Criteria

  • \*Under aged.
  • \*Pregnant.
  • \*Expected to undergo cardiac surgery in the near future.
  • \*Permanent atrial fibrillation.
  • \*Already having a cardiac resynchronisation device implanted previously.
  • \*Pulmonary embolism in the prior 6 months or repeatedly in their lifetime.
  • \*Cerebrovascular incident (CVA or TIA) in the previous 6 months.
  • \*History of clotting or bleeding disorders (i.e. hyper\- and hypocoagulability).

Outcomes

Primary Outcomes

Not specified

Similar Trials